vs
RHYTHM PHARMACEUTICALS, INC.（RYTM）与合众银行（WASH）财务数据对比。点击上方公司名可切换其他公司
RHYTHM PHARMACEUTICALS, INC.的季度营收约是合众银行的1.0倍（$60.1M vs $57.8M），合众银行净利率更高（21.8% vs -92.6%，领先114.3%），过去两年RHYTHM PHARMACEUTICALS, INC.的营收复合增速更高（43.8% vs 9.5%）
Rhythm Pharmaceuticals是一家专注于罕见病领域的生物制药企业，主要开发和商业化针对罕见遗传性肥胖症的靶向疗法，覆盖POMC缺陷、LEPR缺陷、巴德-毕德氏综合征等适应症，服务北美、欧洲地区缺少有效治疗方案的患者群体。
美国合众银行是一家美国跨国金融机构，总部位于明尼苏达州明尼阿波利斯，在特拉华州注册成立。截至2025年，该银行为美国第五大银行，也是美国中西部规模最大的银行，被金融稳定委员会认定为具有系统重要性的金融机构。它主营银行、投资、抵押贷款等多元金融业务。
RYTM vs WASH — 直观对比
营收规模更大
RYTM
是对方的1.0倍
$57.8M
净利率更高
WASH
高出114.3%
-92.6%
两年增速更快
RYTM
近两年复合增速
9.5%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $60.1M | $57.8M |
| 净利润 | $-55.6M | $12.6M |
| 毛利率 | 88.1% | — |
| 营业利润率 | -87.1% | — |
| 净利率 | -92.6% | 21.8% |
| 营收同比 | 83.8% | — |
| 净利润同比 | — | 3.5% |
| 每股收益（稀释后） | $-0.83 | $0.66 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收RYTMWASH
| Q1 26 | $60.1M | $57.8M | ||
| Q4 25 | $57.3M | $59.3M | ||
| Q3 25 | $51.3M | $56.5M | ||
| Q2 25 | $48.5M | $54.3M | ||
| Q1 25 | $32.7M | $59.1M | ||
| Q4 24 | $41.8M | $12.4M | ||
| Q3 24 | $33.3M | $48.5M | ||
| Q2 24 | $29.1M | $48.2M |
净利润RYTMWASH
| Q1 26 | $-55.6M | $12.6M | ||
| Q4 25 | $-47.5M | $16.0M | ||
| Q3 25 | $-52.9M | $10.8M | ||
| Q2 25 | $-46.6M | $13.2M | ||
| Q1 25 | $-49.5M | $12.2M | ||
| Q4 24 | $-43.3M | $-60.8M | ||
| Q3 24 | $-43.6M | $11.0M | ||
| Q2 24 | $-32.3M | $10.8M |
毛利率RYTMWASH
| Q1 26 | 88.1% | — | ||
| Q4 25 | 91.6% | — | ||
| Q3 25 | 89.3% | — | ||
| Q2 25 | 88.6% | — | ||
| Q1 25 | 88.8% | — | ||
| Q4 24 | 90.9% | — | ||
| Q3 24 | 88.5% | — | ||
| Q2 24 | 89.9% | — |
营业利润率RYTMWASH
| Q1 26 | -87.1% | — | ||
| Q4 25 | -82.2% | 34.9% | ||
| Q3 25 | -102.6% | 24.7% | ||
| Q2 25 | -93.4% | 31.6% | ||
| Q1 25 | -143.7% | 26.5% | ||
| Q4 24 | -98.6% | -648.7% | ||
| Q3 24 | -132.0% | 28.5% | ||
| Q2 24 | -139.2% | 28.7% |
净利率RYTMWASH
| Q1 26 | -92.6% | 21.8% | ||
| Q4 25 | -83.0% | 27.0% | ||
| Q3 25 | -103.1% | 19.2% | ||
| Q2 25 | -96.1% | 24.4% | ||
| Q1 25 | -151.4% | 20.6% | ||
| Q4 24 | -103.6% | -491.4% | ||
| Q3 24 | -131.2% | 22.6% | ||
| Q2 24 | -110.9% | 22.4% |
每股收益（稀释后）RYTMWASH
| Q1 26 | $-0.83 | $0.66 | ||
| Q4 25 | $-0.73 | $0.84 | ||
| Q3 25 | $-0.82 | $0.56 | ||
| Q2 25 | $-0.75 | $0.68 | ||
| Q1 25 | $-0.81 | $0.63 | ||
| Q4 24 | $-0.71 | $-3.54 | ||
| Q3 24 | $-0.73 | $0.64 | ||
| Q2 24 | $-0.55 | $0.63 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $340.6M | $12.3M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $122.9M | $546.8M |
| 总资产 | $442.3M | $6.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资RYTMWASH
| Q1 26 | $340.6M | $12.3M | ||
| Q4 25 | $388.9M | — | ||
| Q3 25 | $416.1M | — | ||
| Q2 25 | $291.0M | — | ||
| Q1 25 | $314.5M | — | ||
| Q4 24 | $320.6M | — | ||
| Q3 24 | $298.4M | — | ||
| Q2 24 | $319.1M | — |
股东权益RYTMWASH
| Q1 26 | $122.9M | $546.8M | ||
| Q4 25 | $139.1M | $543.6M | ||
| Q3 25 | $148.8M | $533.0M | ||
| Q2 25 | $-11.9M | $527.5M | ||
| Q1 25 | $18.9M | $521.7M | ||
| Q4 24 | $21.7M | $499.7M | ||
| Q3 24 | $11.2M | $502.2M | ||
| Q2 24 | $39.3M | $471.0M |
总资产RYTMWASH
| Q1 26 | $442.3M | $6.5B | ||
| Q4 25 | $480.2M | $6.6B | ||
| Q3 25 | $506.9M | $6.7B | ||
| Q2 25 | $372.7M | $6.7B | ||
| Q1 25 | $386.7M | $6.6B | ||
| Q4 24 | $392.3M | $6.9B | ||
| Q3 24 | $363.6M | $7.1B | ||
| Q2 24 | $381.8M | $7.2B |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
RYTM
暂无分部数据
WASH
| Net Interest Income | $40.5M | 70% |
| Noninterest Income | $17.3M | 30% |
